Literature DB >> 9857132

Brain drugs of the future.

S Greenfield1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9857132      PMCID： PMC1114485          DOI： 10.1136/bmj.317.7174.1698

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Cell death in Parkinson's disease.

Authors:  S A Greenfield
Journal:  Essays Biochem       Date:  1992       Impact factor: 8.000

Review 3.  Neuropeptides in perspective: the last ten years.

Authors:  T Hökfelt
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

Review 4.  Nitric oxide in the nervous system.

Authors:  J Zhang; S H Snyder
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

Review 5.  Physiology of the neurotrophins.

Authors:  G R Lewin; Y A Barde
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

Review 6.  Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.

Authors:  S Greenfield
Journal:  Neurochem Int       Date:  1996 May-Jun       Impact factor: 3.921

7.  The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture of rat mid-brain.

Authors:  S A Jones; C Holmes; T C Budd; S A Greenfield
Journal:  Cell Tissue Res       Date:  1995-02       Impact factor: 5.249
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.